We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UAL:NASDAQUnited Airlines Holdings, Inc. Analysis

Data as of 2026-03-14 - not real-time

$86.60

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

United Airlines is trading at $86.6, barely above the computed support level of $84.70, while the 20‑day SMA ($103.09) and 50‑day SMA ($108.09) sit well above current prices, indicating a bearish price gap. Technical indicators reinforce this downside bias: the RSI is near 30 (30.49), the MACD histogram is negative and the signal is bearish, and volatility over the past 30 days is extreme at 62%. Market sentiment, however, is in a “Greed” phase (Fear‑Greed Index 72.9), and the Fear‑Greed label suggests investors are still optimistic despite the technical weakness.
Fundamentally, UAL appears significantly undervalued with a trailing P/E of 8.5 versus an industry average of 29.1, a forward P/E of 5.8, and a price‑to‑book of 1.83. The company generates solid operating cash flow ($8.43 B) and free cash flow ($1.10 B), and its ROE of 24% is respectable, though it carries a high debt‑to‑equity ratio (203%). Analyst consensus is strongly positive (24 analysts, “strong_buy”) with a median target of $135.5, implying an upside of roughly 57% from today’s price. Recent material news includes large flight cancellations and a fuel‑cost spike that pressure short‑term earnings, balanced by a new GEnx engine order for its 787 fleet and a $100 M investment in Azul, which could support medium‑ to long‑term growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical setup (RSI near 30, MACD negative)
  • Recent flight cancellations and fuel cost spike
  • Price near key support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Substantial upside to analyst median target (~57%)
  • Low valuation multiples relative to industry
  • New engine fleet investment and strategic partnership with Azul

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong cash generation and solid ROE
  • Industry recovery potential post‑pandemic
  • Analyst consensus of strong‑buy and high target price

Key Metrics & Analysis

Financial Health

Revenue Growth4.80%
Profit Margin5.68%
P/E Ratio8.5
ROE23.99%
ROA4.23%
Debt/Equity203.09
P/B Ratio1.8
Op. Cash Flow$8.4B
Free Cash Flow$1.1B
Industry P/E29.1

Technical Analysis

TrendNeutral
RSI30.5
Support$84.70
Resistance$118.36
MA 20$103.09
MA 50$108.09
MA 200$98.63
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price$136.69
Upside/Downside57.84%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.17
Volatility62.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.